Vivozon Pharmaceutical Co., Ltd. (KOSDAQ:082800)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,890.00
-100.00 (-1.67%)
At close: May 29, 2025, 3:30 PM KST
98.32%
Market Cap 290.84B
Revenue (ttm) 86.33B
Net Income (ttm) -12.77B
Shares Out 49.38M
EPS (ttm) -264.11
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 119,295
Average Volume 108,631
Open 5,970.00
Previous Close 5,990.00
Day's Range 5,840.00 - 6,060.00
52-Week Range 2,910.00 - 13,600.00
Beta -0.77
RSI 30.69
Earnings Date May 13, 2025

About Vivozon Pharmaceutical

Vivozon Pharmaceutical Co., Ltd. researches, develops, produces, and sells LED products primarily in South Korea. The company offers LED packages for interior, general, indoor, decorative, and automotive lighting, as well as display applications. It also provides LED set linear lamps, including panel lamps, down lights, and flood lights for residential, commercial, and industrial structures, as well as lights for parking lots. In addition, the company operates Echo House, a lighting show room that sells LED florescent lamps, LED flat lamps, LED... [Read more]

Industry Electronic Components, not elsewhere classified
Founded 2002
Employees 328
Stock Exchange KOSDAQ
Ticker Symbol 082800
Full Company Profile

Financial Performance

In 2024, Vivozon Pharmaceutical's revenue was 87.60 billion, an increase of 22.83% compared to the previous year's 71.32 billion. Losses were -9.98 billion, 197.3% more than in 2023.

Financial Statements

News

There is no news available yet.